Results 81 to 90 of about 18,836 (198)
Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access
Transplant Infectious Disease, EarlyView.
Jian Mei Li +2 more
wiley +1 more source
Posaconazole Induced Diffuse Lentigines: A Case Report [PDF]
Objective: To report a case of posaconazole induced diffuse lentigines. Case presentation: A 57-year-old Thai male with acute promyelocytic leukemia who received chemotherapy and antifungal drug prophylaxis then appeared abruptly generalized multiple ...
Kittipoom Chinhiran +3 more
core +1 more source
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
Mortality and morbidity due to invasive fungal infections have increased over the years. Posaconazole is a second-generation triazole agent with an extended spectrum of activity, which shows a high interindividual variability in its plasma levels ...
Sarah Allegra +9 more
doaj +1 more source
Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone +9 more
wiley +1 more source
Role of posaconazole in the treatment of oropharyngeal candidiasis
Voichita Ianas1, Kathryn R Matthias2, Stephen A Klotz11Section of Infectious Diseases and Department of Medicine, 2School of Pharmacy, University of Arizona, Tucson, Arizona, USAAbstract: Posaconazole is the newest azole antifungal approved by the US ...
Voichita Ianas +2 more
core
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein
Dengue virus (DENV) is associated with an estimated 390 million infections per year, occurring across approximately 100 countries in tropical and sub-tropical regions.
Overheul, Gijs J +24 more
core +1 more source
Design Considerations for Polymer–Deep Eutectic Solvent Hybrid Systems for Transdermal Drug Delivery
Deep eutectic solvents (DESs) act as tunable, green excipients that modulate polymer structure–property relationships to enhance drug solubility, skin permeation, stability, and controlled release. Through hydrogen‐bond interactions, DES–polymer hybrid systems enable improved transdermal performance, offering a rational, design‐driven platform for ...
Madhavi Kailas Kapale +3 more
wiley +1 more source
Match-making for posaconazole through systems thinking [PDF]
Currently available drugs for Chagas' disease are limited by toxicity and low efficacy in the chronic stage. Posaconazole, the most advanced new anti-chagasic drug candidate, did not fully confirm its initial potential in a Phase II clinical trial for ...
Fügi, Matthias A. +11 more
core +1 more source
Alessandro C. Pasqualotto +4 more
openaire +3 more sources
Pannee Leelawattanachai,1,2 Preecha Montakantikul,1 Wichit Nosoongnoen,1 Methee Chayakulkeeree31Division of Clinical Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Department of Pharmacy, Faculty of ...
Chayakulkeeree M +3 more
core

